A clinical pathway for deep vein thrombosis.
The use of low molecular weight heparin to treat deep vein thrombosis at home represents a relatively new patient population for home care agencies. Use of a clinical pathway provides a framework for defining expected outcomes of care and direction for patient assessment, care, monitoring, and documentation. Implementation and evaluation of a clinical pathway are described.
Gorski
L A
LA
Covenant Home Health & Hospice, Milwaukee, Wisconsin, USA. ml_gorski@msn.com
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D019091:Critical Pathways; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006699:Home Care Services; D006801:Humans; D008297:Male; D008875:Middle Aged; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000451:nursing
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight